Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SexVAP: Sexual Intercourse and Vaginal Progesterone Absorption
NCT05232344Completed
- Sponsor
- CHU Montpellier
- Start
- Apr 2022
- Primary completion
- Feb 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of progesterone in infertility, sponsored by CHU Montpellier. Primary endpoints: Progesterone dosage 1 at Day 3 and Progesterone dosage 2 at Day 7. Started Apr 2022; status: completed.
02
Drugs
progesterone
03
Conditions
infertility
Beyond the preview
Go deeper on NCT05232344.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05232344.